Diabetes 63:24862497 Nauck MA, Petrie JR, Sesti G et al (2016) A phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes
UN: Conceptualization, Project administration, Supervision, Validation, Writing original draft, Writing review & editing
doi: 10.1002/jmv.27050 53 HarringtonV.GurungP
People concerned about AMD or other eye diseases should stay tuned for more robust studies to show if this is a real effect, says Young
Louis Bariatrics, this comes up often, especially from patients who are interested in medications like semaglutide or tirzepatide but feel hesitant about injections